149 related articles for article (PubMed ID: 35367146)
21. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
22. Apoprotein E methylation is correlated with immune microenvironment in hepatocellular carcinoma.
Li J; Tian S; Liu Q; Peng P
Acta Oncol; 2023 Jun; 62(6):550-559. PubMed ID: 37352133
[TBL] [Abstract][Full Text] [Related]
23. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
24. High mRNA Expression of
Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
[TBL] [Abstract][Full Text] [Related]
25. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
26. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
28. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
29. SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular Carcinoma.
Wang Z; Chen X; Jiang Z
Comb Chem High Throughput Screen; 2022; 25(12):2001-2015. PubMed ID: 35081886
[TBL] [Abstract][Full Text] [Related]
30. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
33. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
[TBL] [Abstract][Full Text] [Related]
34. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma.
Wang H; Zhang Y; Yan L; Lv Q; Lu J; Yun B
Int J Immunopathol Pharmacol; 2022; 36():3946320221132986. PubMed ID: 36217828
[TBL] [Abstract][Full Text] [Related]
35. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
36. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
37. STARD5 as a potential clinical target of hepatocellular carcinoma.
Liu Q; Du X; Yu Z; Yao Q; Meng X; Zhang K; Zheng L; Hong W
Med Oncol; 2022 Jul; 39(10):156. PubMed ID: 35852638
[TBL] [Abstract][Full Text] [Related]
38. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
39. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
40. Multiple m
Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
